UCB's Global Corporate Website
Welcome to UCB in the United States
  • Healthcare Professionals
  • Patients
  • Investors

    • Categories

    Archives

    Oct

    25

    BIMZELX® (bimekizumab-bkzx) Three-Year Rheumatology Data at ACR 2025 Demonstrated Sustained Inflammation Control in Psoriatic Arthritis and Axial Spondyloarthritis

    Read More Share:linkedin| twitter| email| facebook

    Nov

    14

    New BIMZELX® (bimekizumab-bkzx) Data at ACR Convergence 2024 Highlights UCB’s Efforts to Deliver Differentiated Care for Patients with Psoriatic Arthritis and Axial Spondyloarthritis

    Read More Share:linkedin| twitter| email| facebook

    Sep

    30

    UCB Announces a Head-to-Head Study Evaluating BIMZELX® (bimekizumab) versus SKYRIZI® (risankizumab) in Active Psoriatic Arthritis

    Read More Share:linkedin| twitter| email| facebook

    Jun

    12

    UCB to share first presentations of BIMZELX® (bimekizumab-bkzx) two-year data in axial spondyloarthritis and psoriatic arthritis at EULAR 2024

    Read More Share:linkedin| twitter| email| facebook

    May

    06

    Evolving Expectations for Arthritis Management

    Read More Share:linkedin| twitter| email| facebook

    Nov

    09

    Advancing Rheumatic Disease Treatment

    Read More Share:linkedin| twitter| email| facebook

    Dec

    07

    The Lancet Publishes Results from Two Bimekizumab Phase 3 Studies in Psoriatic Arthritis

    Read More Share:linkedin| twitter| email| facebook

    May

    23

    UCB Announces First Detailed Data from Two Phase 3 Bimekizumab Studies in Psoriatic Arthritis to be Presented at EULAR 2022

    Read More Share:linkedin| twitter| email| facebook

    May

    12

    Recognizing the Less Common, but Equally Burdensome, Forms of Arthritis During Arthritis Awareness Month

    Read More Share:linkedin| twitter| email| facebook

    Jan

    21

    Positive Top-Line Results for bimekizumab in Second Phase 3 Psoriatic Arthritis Study

    Read More Share:linkedin| twitter| email| facebook

    © 2009 - 2025 UCB, Inc. Atlanta. All rights reserved. 
    Last updated: August 2025